Outsourcing

Agnes Shanley is senior editor of Pharmaceutical Technology.

Articles

Manufacturers and the US government are investing heavily in traditional and non-traditional forms and materials to ensure supplies of containers and delivery devices for COVID-19 treatments and vaccines. 


COVID-19: Shoring Up the Drug Delivery Infrastructure

Contract service organizations can offer biopharma companies early insight into dangers that may hinder a drug’s later development.

Seeking Early Answers to Formulation Questions

Alcami Biologics formed to meet market demands for biological drug development services.

Alcami Announces Biologics Enterprise

The merged companies will provide histopathology services in the research and pre-clinical therapeutics markets. 

Histo-Scientific Research Laboratories and Vet Path Services Merge

ADC Biotechnology will invest downstream formulation, fill/finish capabilities, and Lock-Release conjugation technology.

ADC Bio Secures Additional Equity Round Investment

Formulation issues cause significant drug project delays and project failures, according to a 2018 survey conducted by Informa Pharma Intelligence, Rentschler Biopharma, and LEUKOCARE.

Survey Predicts Drug Product Formulation Recognition and Increasing Budgets

The company says the new equipment will reduce sample turnaround times and increase variant detection quality and accuracy.

Almac Invests in Next-Generation Sequencing Capabilities

Vetter anounced the Open Innovation Challenge to examine the applicability of digital trends to injection systems.

Vetter Launches Use-Centered Approach to Improve Injections

ADC Bio experts warn of impending problems in the ADC pipeline with millions wasted in development costs.

ADC Targets Fail Because of Aggregation Problems

The company has officially opened a local brand office in South Korean to support its existing business in the region.

Contract Services, Formulation and Drug Delivery